Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Risk Predictors in a Spanish Cohort With Cardiac Laminopathies. The REDLAMINA Registry, Predictores de riesgo en una cohorte española con cardiolaminopatías. Registro REDLAMINA

  • Barriales-Villa, Roberto
  • Ochoa, Juan Pablo
  • Larrañaga Moreira, José María
  • Salazar-Mendiguchía, Joel
  • Díez-López, Carles
  • Restrepo-Córdoba, María Alejandra
  • Álvarez-Rubio, Jorge
  • Robles-Mezcua, Ainhoa
  • Olmo-Conesa, María C.
  • Nicolás-Rocamora, Elisa
  • Sanz, Jorge
  • Villacorta, Eduardo
  • Gallego-Delgado, María
  • Yotti, Raquel
  • Espinosa, María Ángeles
  • Manovel, Ana
  • Rincón-Díaz, Luis M.
  • Jiménez-Jáimez, Juan
  • Bermúdez-Jiménez, Francisco J.
  • Basurte-Elorz, M. Teresa
  • Climent-Payá, Vicente
  • García-Álvarez, María I.
  • Rodríguez-Palomares, José Fernando
  • Limeres-Freire, Javier
  • Pérez-Guerrero, Ainhoa
  • Cantero-Pérez, Eva M.
  • Peña-Peña, María Luisa
  • Palomino-Doza, Julián
  • Crespo-Leiro, María Generosa
  • García-Pinilla, José Manuel
  • Zorio, Esther
  • Ripoll-Vera, Tomás
  • García-Pavía, Pablo
  • Ortiz-Genga, Martín
  • Monserrat, Lorenzo
[Abstract] Introduction and objectives. According to sudden cardiac death guidelines, an implantable cardioverter-defibrillator (ICD) should be considered in patients with LMNA-related dilated cardiomyopathy (DCM) and ≥ 2 risk factors: male sex, left ventricular ejection fraction (LVEF) < 45%, nonsustained ventricular tachycardia (NSVT), and nonmissense genetic variants. In this study we aimed to describe the clinical characteristics of carriers of LMNA genetic variants among individuals from a Spanish cardiac-laminopathies cohort (REDLAMINA registry) and to assess previously reported risk criteria. Methods. The relationship between risk factors and cardiovascular events was evaluated in a cohort of 140 carriers (age ≥ 16 years) of pathogenic LMNA variants (54 probands, 86 relatives). We considered: a) major arrhythmic events (MAE) if there was appropriate ICD discharge or sudden cardiac death; b) heart failure death if there was heart transplant or death due to heart failure. Results. We identified 11 novel and 21 previously reported LMNA-related DCM variants. LVEF < 45% (P = .001) and NSVT (P < .001) were related to MAE, but not sex or type of genetic variant. The only factor independently related to heart failure death was LVEF < 45% (P < .001). Conclusions. In the REDLAMINA registry cohort, the only predictors independently associated with MAE were NSVT and LVEF < 45%. Therefore, female carriers of missense variants with either NSVT or LVEF < 45% should not be considered a low-risk group. It is important to individualize risk stratification in carriers of LMNA missense variants, because not all have the same prognosis., [Resumen] Introducción y objetivos. Según las guías de muerte súbita, se debe considerar un desfibrilador automático implantable (DAI) para los pacientes con miocardiopatía dilatada debida a variantes en el gen de la lamina (LMNA) con al menos 2 factores: varones, fracción de eyección del ventrículo izquierdo (FEVI) < 45%, taquicardia ventricular no sostenida (TVNS) y variantes no missense. Nuestro objetivo es describir las características clínicas de una cohorte española de pacientes con cardiolaminopatías (registro REDLAMINA) y evaluar los criterios de riesgo vigentes. Métodos. Se evaluó la relación entre factores de riesgo y eventos cardiovasculares en una cohorte de 140 portadores de variantes en LMNA (54 probandos, 86 familiares, edad ≥ 16 años). Se consideró: a) evento arrítmico mayor (EAM) si hubo descarga apropiada del DAI o muerte súbita, y b) muerte por insuficiencia cardiaca, incluidos los trasplantes. Resultados. Se identificaron 11 variantes nuevas y 21 previamente publicadas. La FEVI < 45% (p = 0,001) y la TVNS (p < 0,001) se relacionaron con los EAM, pero no el sexo o el tipo de variante (missense frente a no missense). La FEVI < 45% (p < 0,001) fue el único factor relacionado con la muerte por insuficiencia cardiaca. Conclusiones. En el registro REDLAMINA, los únicos 2 predictores asociados con EAM fueron la TVNS y la FEVI < 45%. No se debería considerar grupo de bajo riesgo a las portadoras de variantes missense con TVNS o FEVI < 45%. Es importante individualizar la estratificación del riesgo de los portadores de variantes missense en LMNA, porque no todas tienen el mismo pronóstico., This study received a grant from the Proyecto de investigación de la Sección de Insuficiencia Cardiaca 2017 from the Spanish Society of Cardiology and grants from the Instituto de Salud Carlos III (ISCIII) [PI14/0967, PI15/01551, AC16/0014] and ERA-CVD Joint Transnational Call 2016 (Genprovic). Grants from the ISCIII and the Ministerio de Economía y Competitividad de España (Spanish Department of Economy and Competitiveness) are supported by the Plan Estatal de I+D+i 2013-2016: Fondo Europeo de Desarrollo Regional (FEDER) “Una forma de hacer Europa”.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genetic etiology for alcohol-induced cardiac toxicity

  • Ware, James S.
  • Amor-Salamanca, Almudena|||0000-0003-0420-8207
  • Tayal, Upasana
  • Govind, Risha
  • Serrano, Isabel
  • Salazar-Mendiguchía, Joel|||0000-0003-2171-8508
  • García Pinilla, José Manuel|||0000-0001-5999-5741
  • Pascual-Figal, DA.|||0000-0002-4993-9540
  • Núñez, Julio|||0000-0003-1672-7119
  • Guzzo-Merello, Gonzalo
  • González-Vioque, Emiliano
  • Bardají, Alfredo|||0000-0003-1900-6974
  • Manito, Nicolas
  • López-Garrido, Miguel A.
  • Padron-Barthe, Laura
  • Edwards, Elizabeth
  • Whiffin, Nicola
  • Walsh, Roddy
  • Buchan, Rachel J.
  • Midwinter, William
  • Wilk, Alicja
  • Prasad, Sanjay
  • Pantazis, Antonis
  • Baski, John
  • O'Regan, Declan P.
  • Alonso-Pulpón, Luis
  • Cook, Stuart A.
  • Lara-Pezzi, Enrique
  • Barton, Paul J.
  • García-Pavía, Pablo|||0000-0002-5470-2257
Alcoholic cardiomyopathy (ACM) is defined by a dilated and impaired left ventricle due to chronic excess alcohol consumption. It is largely unknown which factors determine cardiac toxicity on exposure to alcohol. This study sought to evaluate the role of variation in cardiomyopathy-associated genes in the pathophysiology of ACM, and to examine the effects of alcohol intake and genotype on dilated cardiomyopathy (DCM) severity. The authors characterized 141 ACM cases, 716 DCM cases, and 445 healthy volunteers. The authors compared the prevalence of rare, protein-altering variants in 9 genes associated with inherited DCM. They evaluated the effect of genotype and alcohol consumption on phenotype in DCM. Variants in well-characterized DCM-causing genes were more prevalent in patients with ACM than control subjects (13.5% vs. 2.9%; p = 1.2 ×10 ⁻⁵), but similar between patients with ACM and DCM (19.4%; p = 0.12) and with a predominant burden of titin truncating variants (TTNtv) (9.9%). Separately, we identified an interaction between TTN genotype and excess alcohol consumption in a cohort of DCM patients not meeting ACM criteria. On multivariate analysis, DCM patients with a TTNtv who consumed excess alcohol had an 8.7% absolute reduction in ejection fraction (95% confidence interval: -2.3% to -15.1%; p < 0.007) compared with those without TTNtv and excess alcohol consumption. The presence of TTNtv did not predict phenotype, outcome, or functional recovery on treatment in ACM patients. TTNtv represent a prevalent genetic predisposition for ACM, and are also associated with a worse left ventricular ejection fraction in DCM patients who consume alcohol above recommended levels. Familial evaluation and genetic testing should be considered in patients presenting with ACM.